Cite
HARVARD Citation
Kolomainen, D. et al. (n.d.). 2758 Is there a survival benefit for patients who receive post-operative adjuvant chemotherapy following secondary cytoreductive surgery (SCRS) for recurrent epithelial ovarian cancer (EOC)?. European journal of cancer. pp. S550-. [Online].